Fosinopril sodium NDC 50090-4743

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-4743Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-4743Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-4743-0	50090474300	30 TABLET in 1 BOTTLE (50090-4743-0)Marketed from Nov 21, 2019
50090-4743-1	50090474301	90 TABLET in 1 BOTTLE (50090-4743-1)Marketed from Nov 21, 2019

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fosinopril sodium
Generic name (nonproprietary): fosinopril sodium
Active ingredients: Fosinopril sodium — 40 mg/1
Dosage form: Tablet
Route: Oral
Labeler: A-S Medication Solutions
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205670
Marketing start: Oct 1, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)
Identifiers: Product ID 50090-4743_43b5f629-a4c7-49dd-a75b-47911757e578SPL ID 43b5f629-a4c7-49dd-a75b-47911757e578SPL set ID 46e3e4e8-c611-4d4f-ad57-050b4c01fcd8RxCUI 857187UNII NW2RTH6T2N
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090474300 followed by a unit qualifier and the quantity

Package 50090-4743-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 25, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Fosinopril sodium tablets are indicated for the treatment of hypertension. They may be used alone or in combination with thiazide diuretics. Fosinopril sodium tablets are indicated in the management of heart failure as adjunctive therapy when added to conventional therapy including diuretics with or without digitalis (see DOSAGE AND ADMINISTRATION ). In using fosinopril sodium, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. Available data are insufficient to show that fosinopril sodium does not have a simila…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 205670

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205670
Product	Strength	Form · route	Labeler	Product NDC
Fosinopril sodiumfosinopirl sodium	Fosinopril sodium 10 mg/1	TabletOral	Bryant Ranch Prepack	71335-0726
Fosinopril sodium	Fosinopril sodium 40 mg/1	TabletOral	Bryant Ranch Prepack	71335-9703
Fosinopril sodiumfosinopirl sodium	Fosinopril sodium 10 mg/1	TabletOral	Solco Healthcare LLC	43547-386
Fosinopril sodium	Fosinopril sodium 20 mg/1	TabletOral	Solco Healthcare LLC	43547-387
Fosinopril sodium	Fosinopril sodium 40 mg/1	TabletOral	Solco Healthcare LLC	43547-388